Euronext suspends Carmat shares after artificial heart patient dies

The death of the 2nd patient implanted with Carmat's artificial heart died over the weekend, prompting the Euronext exchange to suspend trading in the company's stock.

Carmat Inc., Euronext

News Well, Artificial Organs, Cardiac Assist Devices, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1OX3kIh